About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Los Angeles | 142 Studies

Clinical Trials Prostate CancerLos Angeles

Prostate Cancer Clinical Trials in Los Angeles

Find 142 clinical trials for prostate cancer near Los Angeles, California. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Los Angeles

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 142 trials

Active not recruitingA Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).Pfizer MEVPRO-1 (C2321014) is a randomized, open-label, multi-center clinical trial evaluating whether combining the study medicine (PF-06821497) with enzalutamide is safe and…NCT06551324·Homewood, Alabama and 223 others

Prostate Cancer Trials in Other Cities

New York Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedPhase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer PatientsThis is a multi-center, first-in-human, open-label, Phase 1/2A dose-escalation study in which eligible patients with metastatic castration-resistant prostate carcinoma (mCRPC)…NCT02987829·Birmingham, Alabama and 4 others

RecruitingFOG-001 in Locally Advanced or Metastatic Solid TumorsThe goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors or in participants with familial…NCT05919264·Phoenix, Arizona and 32 others

CompletedChemotherapy After Prostatectomy (CAP) For High Risk Prostate CarcinomaVA Cooperative Study #553 is designed to prospectively evaluate the efficacy of early adjuvant chemotherapy using docetaxel and prednisone added to the standard of care for…NCT00132301·Birmingham, Alabama and 33 others

TerminatedA Phase 2 Study of NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin LymphomaThe purpose of this phase 2 study is to evaluate the efficacy and safety of NIR178 in combination with PDR001 in multiple solid tumors and diffuse large B-cell lymphoma (DLBCL)…NCT03207867·Santa Monica, California and 20 others

RecruitingA Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.This study will explore whether a combination of the investigational drug PF-06821497 and enzalutamide will work better than taking enzalutamide alone in participants with mCRPC…NCT06629779·Chandler, Arizona and 230 others

CompletedSystemic and Tumor-Directed Therapy for Oligometastatic Prostate CancerThis is a trial for patients with newly diagnosed metastatic prostate cancer with 5 or fewer sites of metastases.NCT03298087·Long Beach, California and 2 others

RecruitingVascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray TreatmentWith people living longer after being treated for prostate cancer, quality of life has become a concern when considering the treatment plan.NCT07293585·Los Angeles, California

TerminatedA Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular DiseaseThe purpose of this trial is to test if a marketed drug for advanced prostate cancer (FIRMAGON) can reduce the risk of cardiovascular complications as compared to another marketed…NCT02663908·Birmingham, Alabama and 132 others

Active not recruitingStudy Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal TreatmentThe purpose of this study is to evaluate the efficacy and safety of \[Lu-177\]-PNT2002 in patients with metastatic castration-resistant prostate cancer who have progressed…NCT04647526·Tucson, Arizona and 53 others

RecruitingStudy of Oral MRT-2359 With Apalutamide in Prostate CancerThis Phase 2, open-label, multicenter study is conducted in patients with castration-resistant prostate cancer.NCT07745361·Los Angeles, California and 13 others

Active not recruitingVeterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate CancerThis is a prospective, open-label, multi-center seamless phase II to phase III randomized clinical trial designed to compare SST with or without PET-directed local therapy in…NCT04787744·Long Beach, California and 19 others

RecruitingProstate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing ToxicitySingle-arm, prospective registry study assessing changes in acute patient-reported urinary (GU) and gastrointestinal (GI) quality of life at the 24-month post-treatment time point…NCT07077239·Los Angeles, California

RecruitingRole of Race in Nutritional Approach in Men on ADTThere is a well-documented association between androgen deprivation therapy (ADT) and cardiovascular morbidity.NCT06682390·Los Angeles, California and 1 other

RecruitingGolf Recreational Exercise for Enhanced Survivorship in Prostate Cancer SurvivorsThis clinical trial evaluates a golf recreational exercise program for enhancing survivorship in underrepresented prostate cancer survivors.NCT06500169·Los Angeles, California and 1 other

CompletedProspective Assessment of Image Registration for the Diagnosis of Prostate CancerThis is a pilot study to determine cancer detection rate of conventional/systematic versus targeted biopsy methods in diagnosis of potentially lethal prostate cancer.NCT02425228·Los Angeles, California and 1 other

Active not recruitingRadiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal TherapyThis phase I/II trial studies the best dose of M3814 when given together with radium-223 dichloride or with radium-223 dichloride and avelumab and to see how well they work in…NCT04071236·Duarte, California and 31 others

Active not recruitingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)This phase II MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in patients with solid tumors, lymphomas, or multiple…NCT02465060·Birmingham, Alabama and 1409 others

UnknownPSMA PET Scan and mpMRI for Prostate Cancer DetectionProspective, randomized, phase 2 clinical trial to determine if PSMA PET imaging plus mpMRI improves detection of clinically significant prostate cancer as compared to mpMRI alone.NCT05820724·Los Angeles, California

CompletedFocal Laser Ablation of Prostate CancerThe primary objective of this study is to evaluate the safety and feasibility of Magnetic-Resonance(MR)-ultrasound image fusion-guided transrectal-based focal laser ablation (FLA)…NCT04305925·Los Angeles, California

PreviousPage 3 of 8Next

Other Conditions in Los Angeles

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma